These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Lyssenko V; Nagorny CL; Erdos MR; Wierup N; Jonsson A; Spégel P; Bugliani M; Saxena R; Fex M; Pulizzi N; Isomaa B; Tuomi T; Nilsson P; Kuusisto J; Tuomilehto J; Boehnke M; Altshuler D; Sundler F; Eriksson JG; Jackson AU; Laakso M; Marchetti P; Watanabe RM; Mulder H; Groop L Nat Genet; 2009 Jan; 41(1):82-8. PubMed ID: 19060908 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans. Keaton JM; Gao C; Guan M; Hellwege JN; Palmer ND; Pankow JS; Fornage M; Wilson JG; Correa A; Rasmussen-Torvik LJ; Rotter JI; Chen YI; Taylor KD; Rich SS; Wagenknecht LE; Freedman BI; Ng MCY; Bowden DW Genet Epidemiol; 2018 Sep; 42(6):559-570. PubMed ID: 29691896 [TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes is associated with the MTNR1B gene, a genetic bridge between circadian rhythm and glucose metabolism, in a Turkish population. Arikoglu H; Erkoc-Kaya D; Ipekci SH; Gokturk F; Iscioglu F; Korez MK; Baldane S; Gonen MS Mol Biol Rep; 2021 May; 48(5):4181-4189. PubMed ID: 34117605 [TBL] [Abstract][Full Text] [Related]
7. Computational analyses of type 2 diabetes-associated loci identified by genome-wide association studies. Cheng M; Liu X; Yang M; Han L; Xu A; Huang Q J Diabetes; 2017 Apr; 9(4):362-377. PubMed ID: 27121852 [TBL] [Abstract][Full Text] [Related]
8. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Bouatia-Naji N; Bonnefond A; Cavalcanti-Proença C; Sparsø T; Holmkvist J; Marchand M; Delplanque J; Lobbens S; Rocheleau G; Durand E; De Graeve F; Chèvre JC; Borch-Johnsen K; Hartikainen AL; Ruokonen A; Tichet J; Marre M; Weill J; Heude B; Tauber M; Lemaire K; Schuit F; Elliott P; Jørgensen T; Charpentier G; Hadjadj S; Cauchi S; Vaxillaire M; Sladek R; Visvikis-Siest S; Balkau B; Lévy-Marchal C; Pattou F; Meyre D; Blakemore AI; Jarvelin MR; Walley AJ; Hansen T; Dina C; Pedersen O; Froguel P Nat Genet; 2009 Jan; 41(1):89-94. PubMed ID: 19060909 [TBL] [Abstract][Full Text] [Related]
9. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes. Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859 [TBL] [Abstract][Full Text] [Related]
10. A Multi-omic Integrative Scheme Characterizes Tissues of Action at Loci Associated with Type 2 Diabetes. Torres JM; Abdalla M; Payne A; Fernandez-Tajes J; Thurner M; Nylander V; Gloyn AL; Mahajan A; McCarthy MI Am J Hum Genet; 2020 Dec; 107(6):1011-1028. PubMed ID: 33186544 [TBL] [Abstract][Full Text] [Related]
11. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. Fogarty MP; Cannon ME; Vadlamudi S; Gaulton KJ; Mohlke KL PLoS Genet; 2014 Sep; 10(9):e1004633. PubMed ID: 25211022 [TBL] [Abstract][Full Text] [Related]
12. Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go? Bonnefond A; Froguel P Curr Diab Rep; 2017 Oct; 17(12):122. PubMed ID: 29063374 [TBL] [Abstract][Full Text] [Related]
13. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression. Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024 [TBL] [Abstract][Full Text] [Related]
14. Joint effect of CENTD2 and KCNQ1 polymorphisms on the risk of type 2 diabetes mellitus among Chinese Han population. Qian Y; Dong M; Lu F; Li H; Jin G; Hu Z; Shen C; Shen H Mol Cell Endocrinol; 2015 May; 407():46-51. PubMed ID: 25749274 [TBL] [Abstract][Full Text] [Related]
15. Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. Liu CT; Raghavan S; Maruthur N; Kabagambe EK; Hong J; Ng MC; Hivert MF; Lu Y; An P; Bentley AR; Drolet AM; Gaulton KJ; Guo X; Armstrong LL; Irvin MR; Li M; Lipovich L; Rybin DV; Taylor KD; Agyemang C; Palmer ND; Cade BE; Chen WM; Dauriz M; Delaney JA; Edwards TL; Evans DS; Evans MK; Lange LA; Leong A; Liu J; Liu Y; Nayak U; Patel SR; Porneala BC; Rasmussen-Torvik LJ; Snijder MB; Stallings SC; Tanaka T; Yanek LR; Zhao W; Becker DM; Bielak LF; Biggs ML; Bottinger EP; Bowden DW; Chen G; Correa A; Couper DJ; Crawford DC; Cushman M; Eicher JD; Fornage M; Franceschini N; Fu YP; Goodarzi MO; Gottesman O; Hara K; Harris TB; Jensen RA; Johnson AD; Jhun MA; Karter AJ; Keller MF; Kho AN; Kizer JR; Krauss RM; Langefeld CD; Li X; Liang J; Liu S; Lowe WL; Mosley TH; North KE; Pacheco JA; Peyser PA; Patrick AL; Rice KM; Selvin E; Sims M; Smith JA; Tajuddin SM; Vaidya D; Wren MP; Yao J; Zhu X; Ziegler JT; Zmuda JM; Zonderman AB; Zwinderman AH; ; ; ; ; ; Adeyemo A; Boerwinkle E; Ferrucci L; Hayes MG; Kardia SL; Miljkovic I; Pankow JS; Rotimi CN; Sale MM; Wagenknecht LE; Arnett DK; Chen YD; Nalls MA; ; Province MA; Kao WH; Siscovick DS; Psaty BM; Wilson JG; Loos RJ; Dupuis J; Rich SS; Florez JC; Rotter JI; Morris AP; Meigs JB Am J Hum Genet; 2016 Jul; 99(1):56-75. PubMed ID: 27321945 [TBL] [Abstract][Full Text] [Related]
16. From Genetic Association to Molecular Mechanisms for Islet-cell Dysfunction in Type 2 Diabetes. Mattis KK; Gloyn AL J Mol Biol; 2020 Mar; 432(5):1551-1578. PubMed ID: 31945378 [TBL] [Abstract][Full Text] [Related]
17. Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci. Thurner M; van de Bunt M; Torres JM; Mahajan A; Nylander V; Bennett AJ; Gaulton KJ; Barrett A; Burrows C; Bell CG; Lowe R; Beck S; Rakyan VK; Gloyn AL; McCarthy MI Elife; 2018 Feb; 7():. PubMed ID: 29412141 [TBL] [Abstract][Full Text] [Related]
18. Transancestral fine-mapping of four type 2 diabetes susceptibility loci highlights potential causal regulatory mechanisms. Horikoshi M; Pasquali L; Wiltshire S; Huyghe JR; Mahajan A; Asimit JL; Ferreira T; Locke AE; Robertson NR; Wang X; Sim X; Fujita H; Hara K; Young R; Zhang W; Choi S; Chen H; Kaur I; Takeuchi F; Fontanillas P; Thuillier D; Yengo L; Below JE; Tam CH; Wu Y; Abecasis G; Altshuler D; Bell GI; Blangero J; Burtt NP; Duggirala R; Florez JC; Hanis CL; Seielstad M; Atzmon G; Chan JC; Ma RC; Froguel P; Wilson JG; Bharadwaj D; Dupuis J; Meigs JB; Cho YS; Park T; Kooner JS; Chambers JC; Saleheen D; Kadowaki T; Tai ES; Mohlke KL; Cox NJ; Ferrer J; Zeggini E; Kato N; Teo YY; Boehnke M; McCarthy MI; Morris AP; Hum Mol Genet; 2016 May; 25(10):2070-2081. PubMed ID: 26911676 [TBL] [Abstract][Full Text] [Related]
19. Genetic architecture of type 2 diabetes. Hara K; Shojima N; Hosoe J; Kadowaki T Biochem Biophys Res Commun; 2014 Sep; 452(2):213-20. PubMed ID: 25111817 [TBL] [Abstract][Full Text] [Related]
20. Single-cell ATAC-Seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures. Rai V; Quang DX; Erdos MR; Cusanovich DA; Daza RM; Narisu N; Zou LS; Didion JP; Guan Y; Shendure J; Parker SCJ; Collins FS Mol Metab; 2020 Feb; 32():109-121. PubMed ID: 32029221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]